Prevalence of non-excessive users | Prevalence of excessive users > 365 DDD, < 730 DDD | Prevalence of excessive users > 730 DDD | Model R2 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regr coeff | SE | p-value | Beta | Regr coeff | SE | p-value | Beta | Regr coeff | SE | p-value | Beta | ||
Carisoprodol | 0.026 | 0.007 | .002 | .543 | 1.243 | 0.412 | .008 | .439 | - | - | - | 0.864 | |
Codeine | - | - | - | 1.761 | 0.120 | <.001 | .961 | - | - | - | 0.923 | ||
Diazepam | 0.066 | 0.006 | <.001 | .403 | 0.771 | 0.057 | <.001 | .483 | 1.176 | 0.172 | <.001 | .231 | 0.989 |
Oxazepam | 0.052 | 0.004 | <.001 | .536 | 1.058 | 0.078 | <.001 | .490 | - | - | - | 0.995 | |
Nitrazepam | 0.105 | 0.010 | <.001 | .353 | 0.583 | 0.038 | <.001 | .507 | 1.168 | 0.109 | <.001 | .182 | 0.998 |
Flunitrazepam | 0.142 | 0.013 | <.001 | .351 | 0.427 | 0.048 | <.001 | .331 | 1.470 | 0.076 | <.001 | .464 | 0.993 |
Zopiclone | 0.070 | 0.015 | <.001 | .192 | 0.851 | 0.055 | <.001 | .749 | 0.602 | 0.251 | .029 | .085 | 0.993 |
Zolpidem | 0.069 | 0.007 | <.001 | .409 | 0.693 | 0.063 | <.001 | .447 | 1.305 | 0.229 | <.001 | .242 | 0.988 |
Anxiolytics (also including alprazolam) | 0.024 | 0.006 | .002 | .200 | 1.021 | 0.148 | <.001 | .526 | 1.489 | 0.246 | <.001 | .353 | 0.979 |
Hypnotics (also including clomethiazole) | 0.072 | 0.019 | .002 | .182 | 0.747 | 0.053 | <.001 | .676 | 1.042 | 0.182 | <.001 | .182 | 0.994 |
All studied drugs | 0.051 | 0.018 | .012 | .118 | 0.707 | 0.087 | <.001 | .449 | 1.437 | 0.138 | <.001 | .485 | 0.990 |